Ton Bolier, MD
Dr. Bolier has been active as a psychiatrist in mental health care for over 20 years. During his medical practice, he became involved in the support and management of startups. Since the late 90’s this has become his primary activity. In December 2009 Dr. Bolier joined the Supervisory Board at Alloksys.
Nandiraju Manohar
Nandiraju Manohar (Manu) is the CEO of ICM Pharma Pte Ltd., a leading Singapore-based, GMP-certified pharmaceutical manufacturer. Manu has over 14 years experience in senior management roles, providing direction and leadership to fulfil the growth and profitability objectives. Prior to joining the ICM group in Sep 2016, he has served as the Managing Director of Drug Houses of Australia, a Teva group company.
Bert Tournois, PhD
Dr. Tournois Started his professional carreer in the research institute ATO-DLO (1989-2000) where he held various management positions, eventually becoming director of the Business Units Food and Non Food technology. In 2005 he joined the institute directorate as commercial director. In 2000 he founded TDI, a Venture Catalyst Company and since then over 30 startups in medical, agrotechnology and food, including TOP, Holland Food Ventures, Chez Pascal, Ojah, Phycom, Medlogics.
Frans van Duikeren
Frans van Duikeren has a degree in Food Technology (Wageningen UR) and management Consultancy (SIOO). Van Duikeren worked from 1978 until 2003 in the packaging industry, last fifteen years in general management in internationals. From 2004 van Duikeren started a small business consultancy company to support management of starting businesses and SME’s. From 2005 he also acts as an informal investor mainly in life sciences.
![IMG_6069 (1)[2]](https://www.alloksys.com/wp-content/uploads/elementor/thumbs/IMG_6069-12-pks2uild975kwk7lpjph09n6h8er6sbf7lfzlz2lr8.jpg "IMG_6069 (1)[2]")
Daan van den Noort MD
Daan van den Noort has over 30 years of experience as a manager and venture capitalist in the pharmaceutical and biotech industry in Europe. His positions include being a General Manager at Genentech, Asta Medica and Ferring Pharmaceuticals in The Netherlands. From 2001 until 2011, he acted as Chief Investment Officer of the Biotech Turnaround Fund (BTF), a Dutch venture capital company. He served on the boards of several international investment companies active in the biopharmaceutical industry, holds external advisors hips with several national and international investment companies, and is a supervisory board member of several SME biotech companies such as Alloksys Life Sciences and AMRIF. Daan has an MD degree from the Free University of Amsterdam.